Home > Balance Sheet > PIRAMAL PHARMA

PIRAMAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-145 Cr₹-157 Cr₹-130 Cr₹-105 Cr₹-22 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of PIRAMAL PHARMA is ₹-145 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-145 Cr
Mar2024₹-157 Cr
Mar2023₹-130 Cr
Mar2022₹-105 Cr
Mar2021₹-22 Cr

How is Deferred Tax Assets / Liabilities of PIRAMAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-145 Cr
Negative
Mar2024 ₹-157 Cr
Negative
Mar2023 ₹-130 Cr
Negative
Mar2022 ₹-105 Cr
Negative
Mar2021 ₹-22 Cr -

Compare Deferred Tax Assets / Liabilities of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,078.0 Cr 0.3% 0.3% -19.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.4% 2.6% NA Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr -4.5% 0.7% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 5% 4.1% 37.2% Stock Analytics
CIPLA ₹108,978.0 Cr -0.5% -3.4% -6.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 1.2% 10.2% 4.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.3%

0.3%

-19.6%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses